Skip to main content
Have a personal or library account? Click to login
The technologies used for developing orally disintegrating tablets: A review Cover

The technologies used for developing orally disintegrating tablets: A review

By:  and    
Open Access
|Jun 2011

References

  1. , 5ed., Council of Europe, Strasbourg, 2006, p. 628.
  2. S. Bandari, R. K. Mittapalli and Y. M. Gannu Rao, Orodispersible tablet: An overview,(2008) 2-11. DOI: 10.4103/0973-8398.41557.
  3. V. Agarwal, B. H. Kothari, D. V. Moe and R. K. Khankari,(Ed. James Swarbrick), Informa Healthcare, New York 2006, pp. 1104-1114.
  4. S. V. Sastry, J. R. Nyshadham and J. A. Fix, Recent technological advances in oral drug delivery - a review,(2000) 138-145. DOI: 10.1016/S1461-5347(00)00247-9.
  5. P. Virely and R. Yarwood, Zydis - a novel fast dissolving dosage form,(1990) 36-37.
  6. S. W. Avery and D. M. Dellarosa, Approaches to treating dysphagia in patients with brain injury,(1994) 235-239.
  7. P. J. Kahrilas, Anatomy, physiology and pathophysiology of dysphagia,(1994) 97-117.
  8. C. G. Wilson, N. Washington, J. Peach, G. R. Murray and J. Kennerley, The behavior of a fast dissolving dosage form (Expidet) followed by γ-scintigraphy,(1987) 119-123; DOI: 10.1016/0378-5173(87)90056-1.
  9. R. Chandrasekhar, Z. Hassan, F. Alhusban, A. M. Smith and A. R. Mohammed, The role of formulation excipients in the development of lyophilized fast-disintegrating tablets,(2009) 119-129; DOI: 10.1016/j.ejpb.2008.11.011.
  10. I. S. Ahmed, M. M. Nafadi and F. A. Fatahalla, Formulation of fast-dissolving ketoprofen tablet using freeze-drying in blisters technique,(2006) 437-442; DOI: 10.1080/03639040500528913.
  11. S. Kundu and P. K. Sahoo, Recent trends in the developments of orally disintegrating tablet technology,(2008) 11-15.
  12. A. S. Mundada, S. Jain, N. O. Chachda and J. G. Avari, Taste masking approaches - a review: Part I,(2008) 94-102.
  13. A. S. Mundada, S. Jain, N. O. Chachda and J. G. Avari, Taste masking approaches - a review: Part II,(2008) 74-82.
  14. P. Busson and M. Schroeder,, U.S. Pat. 6,534,087, 18 Mar 2003.
  15. A. Fini, V. Bergamante, G. C. Ceschel, C. Ronchi and C. A. Fonseca de Moraes, Fast dispersible/slow releasing ibuprofen tablets,(2008) 335-341; DOI: 10.1016/j.ejpb.2007.11.011.
  16. K. G. Mohamed and C. A. Moji, High shear mixing granulation of ibuprofen and β-cyclodextrin: effects of process variables on ibuprofen dissolution,(2007) 84; DOI: 10.1208/pt0804084.
  17. K. Masters,, in, 5ed., Longman Scientific & Technical, New York 1991, pp. 23-64.
  18. J. Xu, L. L. Bovet and K. Zhao, Taste masking microspheres for orally disintegrating tablets,(2008) 63-69; DOI: 10.1016/j.ijpharm.2008.03. 019.
  19. L. Hughes, Selecting the right ion exchange resin,(2005) 54-56.
  20. N. Prasad, D. Straus and G. Reichart,, U.S. Pat. 6,287,603, 11 Sep 2001.
  21. S. H. Jeong and K. Park, Development of sustained release fast-disintegrating tablets using various polymer-coated ion-exchange resin complexes,(2008) 195-204; DOI: 10.1016/j.ijpharm.2007.11.033.
  22. D. P. Venkatesh and C. G. Geetha Rao, Formulation of taste masked orodispersible tablets of ambroxol hydrochloride,(2008) 261-264; DOI: 10.4103/0973-8398.45043.
  23. J. A. Bakan,, in(Eds. H. A. Lieberman, L. Lanchman and J. L. Kanig), Varghese Publishing House, Bombay 1987, p. 420.
  24. A. Y. Ozer and A. A. Hincal, Studies on the masking of unpleasant taste of beclamide: micro-encapsulation and tableting,(1990) 327-339.
  25. R. O'Connor and J. Schwartz,, in, Vol. 37, Marcel Dekker Inc., New York 1989, pp. 116-120.
  26. P. S. Zade, P. S. Kawtikwar and D. M. Sakharkar, Formulation, evaluation and optimization of fast dissolving tablet containing tizanidine hydrochloride,(2009) 34-42.
  27. T. Yajima, N. Umeki and S. Itai, Optimum spray congealing condition for masking the bitter taste of clarithromycin in wax matrix,(1999) 220-225.
  28. S. L. Nail, L. A. Gatlin,, in, Marcel Dekker, New York 1993, p. 163.
  29. P. Kearney and S. K. Wong,, U.S. Pat. 5 631 023, 20 May 1997.
  30. P. Kearney,, in(Eds. M. J. Rathbone, J. Hadgraft and M. S. Roberts), Marcel Dekker Inc., New York 2003, pp. 191-201.
  31. H. Seager, Drug delivery product and the Zydis fast-dissolving dosage form,(1998) 375-382; DOI: 10.1111/j.2042-7158.
  32. L. Dobetti, Fast-melting tablets: Developments and technologies,(2001) 44-50.
  33. S. Corveleyn and J. P. Remon, Formulation and production of rapidly disintegrating tablets by lyophilization using hydrochlorothiazide as a model drug,(1997) 215-225; DOI: 10.1016/S0378-5173(97)00092-6.
  34. D. Kaushik, S. Dureja and T. R. Saini, An overview of melt in mouth tablet technologies and techniques,(2004) 35-37.
  35. R. G. Blank, D. S. Mody, R. J. Kenny and M. C. Aveson,, U.S. Pat. 4946684, 9 May 1990.
  36. K. Masaki,, U.S. Pat. 5,466,464, 14 Nov 1995.
  37. A. Modi and P. Tayade, Enhancement of dissolution profile by solid dispersion (kneading) technique,(2006) Article 68; DOI: 10.1208/pt070368.
  38. R. Laitinen, E. Suihko, K. Toukola, M. Bjorkqvist, J. Riikonen, V. P. Lehto, K. Jarvinen and J. Ketolainen, Intraorally fast-dissolving particles of a poorly soluble drug: Preparation and in vitro characterization,(2009) 271-281; DOI: 10.1016/j.ejpb.2008.09.001.
  39. T. M. Harmon, Orally disintegrating tablets: A valuable life cycle management strategy,(2007) 1-4.
  40. T. E. Chiver and O. Minn,, U.S. Pat. 7,30,057, 13 Feb 2003.
  41. G. L. Mayers, G. E. Battisk and R. C. Fluiz,, PCT Pat. WC 95/24293-A1, 1995.
  42. T. Mizumoto, Y. Masuda, T. Yamamoto, E. Yonemochi and K. Terada, Formulation design of a novel fast-disintegrating tablet,(2005) 83-90; DOI: 10.1016/j.ijpharm.2005.09.009.
  43. M. Sugimoto, S. Narisawa, K. Matsubara, H. Yoshino, M. Nakano and T. Handa, Development of manufacturing method for rapidly disintegrating oral tablets using the crystalline transition of amorphous sucrose,(2006) 71-78; DOI: 10.1016/j.ijpharm.2006.04.004.
  44. M. Sugimoto, S. Narisawa, K. Matsubara, H. Yoshino, M. Nakano and T. Handa, Effect of formulated ingredients on rapidly disintegrating oral tablets prepared by the crystalline transition method,(2006) 175-180.
  45. G. Abdelbary, P. Prinderre, C. Eouani, J. Joachim, J. P. Reynier and P. H. Piccerelle, The preparation of orally disintegrating tablets using a hydrophilic waxy binder,(2004) 423-433; DOI: 10.1016/j.ijpharm.2004.03.023.
  46. G. Abdelbary, C. Eouani, P. Prinderre, J. Joachim, J. P. Reynier and P. H. Piccerelle, Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration,(2005) 29-41; DOI: 10.1016/j.ijpharm.2004.08.019. 26.
  47. B. Perissutti, F. Rubessa, M. Moneghini and D. Voinovich, Formulation design of carbamazepine fast-release tablets prepared by melt granulation technique,(2003) 53-63; DOI: 10.1016/0378-5173(89)90061-6.
  48. Y. Kuno, M. Kojima, S. Ando and H. Nakagami, Effect of preparation method on properties of orally disintegrating tablets made by phase transition,(2008) 87-92; DOI: 10.1016/j.ijpharm.2007.11.046.
  49. Y. Kuno, M. Kojima, H. Nakagami, E. Yonemochi and K. Terada, Effect of the type of lubricant on the characteristics of orally disintegrating tablets manufactured using the phase transition of sugar alcohol,(2008) 986-992; DOI: 10.1016/j.ejpb.2008.02.016.
  50. D. M. Patel and M. M. Patel, Optimization of fast dissolving etoricoxib tablet by sublimation technique,(2008) 71-76; DOI: 10.4103/0250-474X.40335.
  51. S. Suresh, V. Pandit and P. Joshi, Preparation and evaluation of mouth dissolving tablet of salbutamol sulphate,(2007) 467-469; DOI: 10.4103/0250-474X.34568.
  52. B. J. Roser and J. Blair,, U.S. Pat. 5,762,961, 9 June 1998.
  53. Y. Yamamoto, M. Fujii, K. Watanabe, M. Tsukamoto, Y. Shibata, M. Kondoh and Y. Watanabe, Effect of powder characteristics on oral tablet disintegration,(2009) 116-120; DOI: 10.1016/j.ijpharm. 2008.08.031.
  54. M. El-Barghouthi, A. Eftaiha, I. Rashid, M. Ai. Remarps and A. Badwan, A novel superdisintegrating agent made from physically modified chitosan with silicon dioxide,(2008) 373-383; DOI: 10.1080/03639040701657792.
  55. Y. Bi, H. Sunada, Y. Yonezawa, K. Danjo, A. Otsuka and K. Iida, Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity,(1996) 2121-2127.
  56. A. Ito and M. Sugihara, Development of oral dosage form for elderly patients: Use of agar as base of rapidly disintegrating oral tablets,(1996) 2132-2136.
  57. S. G. Gattani, B. G. Shiyani, K. N. Kakade, A. B. Patil and S. J. Surana, Formulation and development of mouth dissolving tablet of ondensetron hydrochloride by using superdisintegrants,(2009) 44-50.
  58. J. Fukami, A. Ozawa, Y. Yoshihashi, E. Yonemochi and K. Terada. Development of fast disintegrating compressed tablets using amino acid as disintegration accelerator: evaluation of wetting and disintegration of tablet on the basis of surface free energy,(2005) 1536-1539.
  59. T. Koseki, H. Onishin, Y. Takahashi, M. Uchida and Y. Machida, Development of novel fast-disintegrating tablets by direct compression using sucrose stearic acid ester as a disintegration-accelerating agent,(2008) 1384-1388.
  60. T. Shu, H. Suzuki, K. Hironaka and K. Ito, Studies of rapidly disintegrating tablets in the oral cavity using co-ground mixtures of mannitol with crospovidone,(2002) 193-198.
  61. S. G. Late, Y. Yu and A. K. Banga, Effects of disintegration-promoting agent, lubricants and moisture treatment on optimized fast disintegrating tablets,(2009) 4-11; DOI: 10.1016/j.ijpharm. 2008.08.010.
  62. N. Zhao and L. L. Augsburger, The influence of granulation on superdisintegrant performance,(2006) 47-53.
  63. P. Di Martino, S. Martelli and P. Wehrle, Evaluation of different fast melting disintegrants by means of a central composite design,(2005) 109-121; DOI: 10.1081/DDC-44233.
  64. A. A. Joshi and D. Xavier, Added functionally excipients: An answer to challenging formulations,2004, 12-19.
  65. N. Zhao and L. L. Augsburger, The influence of product brand-to-brand variability on superdisintegrant performance. A case study with croscarmellose sodium,(2006) 179-185.
  66. Y. Fu, S. H. Jeong and K. Park, Fast-melting tablets based on highly plastic granules,(2005) 203-210; DOI: 10.1016/j.jconrel.2005.09.021.
  67. J. Shery, A. Shirwaikar and A. Nair, Preparation and evaluation of fast-disintegrating effervescent tablets of glibenclamide,(2009) 321-328; DOI: 10.1080/03639040802337021.
  68. G. S. Bankar and N. R. Anderson,, in(Eds. L. Lanchman, H. A. Lieberman and J. L. Kanig), Varghese Publishing House, Bombay 1987, pp. 293-345.
  69. F. Wehling, S. Schuehle and N. Madamala,, U.S. Pat. 5,178,878, 12 Jan 1993.
  70. F. Wehling, S. Schuehle and N. Madamala,, U.S. Pat. 5,223,264, 29 Jun 1993.
  71. F. Wehling and S. Schuehle,, U.S. Pat. 5,503,846, 2 Apr 1996.
  72. M. C. Iles, A. D. Atherton and N. M. Copping,, U.S. Pat. 5,188,825, 23 Feb 1993.
  73. S. R. Cherukuri, G. L. Myers, G. E. Battist and R. C. Fuisz,, U.S. Pat. 5,587,172, 24 Dec 1996.
  74. R. C. Fuisz,, U.S. Pat. 5,622,717, 22 Apr 1997.
  75. S. R. Cherukuri and R. Fuisz,, Eur. Pat. 0677,147 A2, 1995.
  76. G. L. Myers, G. E. Battist and R. C. Fuisz,, U.S. Pat. 5,567, 439, 22 Oct 1996.
  77. G. L. Myers, G. E. Battist and R. C. Fuisz,, U.S. Pat. 5,871,781, 16 Feb 1999.
  78. S. R. Cherukuri and R. Fuisz,, U.S. Pat. 5,654,003, 5 Aug 1997.
  79. G. L. Myers, G. E. Battist and R. C. Fuisz,, U.S. Pat. 5,622,719, 22 April 1997.
  80. L. Lafon., Eur. Pat. 0,159,237, 1985.
  81. A. C. Liang and H. Chen Li-Lan, Fast-dissolving intraoral drug delivery systems,(2001) 981-986; DOI: 10.1517/13543776.11.6.981.
  82. W. R. Pfister, L. H. Chen and D. W. Ren,, U.S. Pat. 6,552,024, 22 Apr 2003.
DOI: https://doi.org/10.2478/v10007-011-0020-8 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English, Croatian
Page range: 117 - 139
Published on: Jun 17, 2011
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Related subjects:

© 2011 Bhatu Badgujar, Atish Mundada, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.